Drug intelligence / Profile preview

Kanglao Gujin Granules

Development stage
Unknown
Lead developer
Beijing Chest Hospital
Administration
Oral
01

Overview

Kanglao Gujin Granules is a Traditional Chinese Medicine (TCM) herbal formulation primarily utilized as an adjuvant therapy for pulmonary tuberculosis (PTB). Developed as a hospital preparation by the Beijing Chest Hospital, it is specifically indicated for patients exhibiting the "Lung-Kidney Yin Deficiency" pattern, characterized by symptoms such as chronic cough, night sweats, and hemoptysis. The formulation consists of several botanical ingredients, including *Glehnia littoralis*, *Rehmannia glutinosa*, and *Ophiopogon japonicus*, which are traditionally believed to nourish Yin and moisten the lungs. In clinical settings, it is typically administered alongside standard first-line anti-tuberculosis chemotherapy (HRZE regimen) to improve clinical efficacy, accelerate the absorption of pulmonary lesions, and potentially reduce the adverse effects associated with long-term synthetic antibiotic use.

Brand names
抗痨固金颗粒Kanglao Gujin Granules
Other names
Kanglao Gujin KeliKanglao Gujin

Beyond the preview

Go deeper on Kanglao Gujin Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kanglao Gujin Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call